Company:  CORCEPT THERAPEUTICS INC (CORT)
Form Type:  8-K
Filing Date:  8/13/2021 
CIK:  0001088856 
Address:  149 COMMONWEALTH DRIVE 
City, State, Zip:  MENLO PARK, California 94025 
Telephone:  650.688.8803 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$18.72  
Change: 
-0.09 (-0.48%)  
Trade Time: 
Oct 22  
Market Cap: 
$2.17B
Trade CORT now with 

© 2021  
Description of Business
We are a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the steroid hormone cortisol. Cortisol plays a significant role in the body's response to stress and is essential for survival. Cortisol influences metabolism and the immune system and contributes to emotional stability. Cortisol levels follow a diurnal rhythm that is essential to health, peaking upon awakening and decreasing during the day. Insufficient cortisol activity may lead to dehydration, hypotension, shock, fatigue and hypoglycemia. Excessive cortisol activity, known as hypercortisolism, may lead to a suppressed immune response, impaired glucose tolerance, diabetes, obesity, fatty liver disease, depressed mood, psychosis, wasting of the arms and legs, edema, fatigue, hypertension and other problems.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain Officers; ...
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 10.1
  EXHIBIT 99.1